Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Non-steroidal anti-inflammatory drugs increase MRP4 expression in an endometriotic epithelial cell line in a PPARa dependent manner.

Massimi I, Pulcinelli FM, Piscitelli VP, Alemanno L, Maltese T, Guarino ML, Marci R, Canny GO, Frati L, Mallozzi M, Frega A, Caserta D.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8487-8496. doi: 10.26355/eurrev_201812_16549.

2.

The role of female hormonal factors in the development of rheumatoid arthritis.

Alpízar-Rodríguez D, Pluchino N, Canny G, Gabay C, Finckh A.

Rheumatology (Oxford). 2017 Aug 1;56(8):1254-1263. doi: 10.1093/rheumatology/kew318. Review.

PMID:
27686101
3.

Disrupting Y-Box-Binding Protein 1 Function Using OSU-03012 Prevents Endometriosis Progression in In Vitro and In Vivo Models.

Silveira CGT, Marschner G, Canny GO, Klocke S, Hunold P, Köster F, Ahrens T, Rody A, Hornung D.

Reprod Sci. 2017 Jan;24(1):67-76. doi: 10.1177/1933719116649695. Epub 2016 Sep 27.

PMID:
27217374
4.

Proteome-Wide Effect of 17-β-Estradiol and Lipoxin A4 in an Endometriotic Epithelial Cell Line.

Sobel JA, Waridel P, Gori I, Quadroni M, Canny GO.

Front Endocrinol (Lausanne). 2016 Jan 6;6:192. doi: 10.3389/fendo.2015.00192. eCollection 2015.

5.

Outcome in patients with cystic fibrosis liver disease.

Rowland M, Gallagher C, Gallagher CG, Laoide RÓ, Canny G, Broderick AM, Drummond J, Greally P, Slattery D, Daly L, McElvaney NG, Bourke B.

J Cyst Fibros. 2015 Jan;14(1):120-6. doi: 10.1016/j.jcf.2014.05.013. Epub 2014 Jun 7.

6.

Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling.

Kumar R, Clerc AC, Gori I, Russell R, Pellegrini C, Govender L, Wyss JC, Golshayan D, Canny GO.

PLoS One. 2014 Feb 24;9(2):e89742. doi: 10.1371/journal.pone.0089742. eCollection 2014.

7.

L1 cell adhesion molecule as a potential therapeutic target in murine models of endometriosis using a monoclonal antibody approach.

Silveira CG, Finas D, Hunold P, Köster F, Stroschein K, Canny GO, Moldenhauer G, Altevogt P, Rody A, Hornung D.

PLoS One. 2013 Dec 4;8(12):e82512. doi: 10.1371/journal.pone.0082512. eCollection 2013.

8.

Active video games as an exercise tool for children with cystic fibrosis.

O'Donovan C, Greally P, Canny G, McNally P, Hussey J.

J Cyst Fibros. 2014 May;13(3):341-6. doi: 10.1016/j.jcf.2013.10.008. Epub 2013 Nov 1.

9.

Cell line contamination and misidentification.

Canny G.

Biol Reprod. 2013 Sep 27;89(3):76. doi: 10.1095/biolreprod.113.113423. Print 2013 Sep. No abstract available.

PMID:
24078722
10.

Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

Davies JC, Wainwright CE, Canny GJ, Chilvers MA, Howenstine MS, Munck A, Mainz JG, Rodriguez S, Li H, Yen K, Ordoñez CL, Ahrens R; VX08-770-103 (ENVISION) Study Group.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1219-25. doi: 10.1164/rccm.201301-0153OC.

11.

The role of lipoxin A4 in endometrial biology and endometriosis.

Canny GO, Lessey BA.

Mucosal Immunol. 2013 May;6(3):439-50. doi: 10.1038/mi.2013.9. Epub 2013 Mar 13. Review.

12.

Augmented epithelial multidrug resistance-associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A(4).

Gori I, Rodriguez Y, Pellegrini C, Achtari C, Hornung D, Chardonnens E, Wunder D, Fiche M, Canny GO.

Fertil Steril. 2013 Jun;99(7):1965-73.e2. doi: 10.1016/j.fertnstert.2013.01.146. Epub 2013 Mar 6.

PMID:
23472950
13.

Hemoptysis from bronchial varices associated with pulmonary vein stenosis: role of surgical repair.

Walsh A, Canny G, McMahon CJ, Redmond JM, McNally P.

Pediatr Pulmonol. 2013 Aug;48(8):838-40. doi: 10.1002/ppul.22659. Epub 2012 Sep 19.

PMID:
22997173
14.

The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis.

Pellegrini C, Gori I, Achtari C, Hornung D, Chardonnens E, Wunder D, Fiche M, Canny GO.

Fertil Steril. 2012 Nov;98(5):1200-8. doi: 10.1016/j.fertnstert.2012.06.056. Epub 2012 Aug 11.

PMID:
22884659
15.

The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study.

Cox DW, Kelly C, Rush R, O'Sullivan N, Canny G, Linnane B.

Ir Med J. 2011 Nov-Dec;104(10):305-8.

PMID:
22256443
16.

Compartmentalized secretory leukocyte protease inhibitor expression and hormone responses along the reproductive tract of postmenopausal women.

Kumar R, Vicari M, Gori I, Achtari C, Fiche M, Surbeck I, Damnon F, Canny GO.

J Reprod Immunol. 2011 Dec;92(1-2):88-96. doi: 10.1016/j.jri.2011.06.103. Epub 2011 Sep 22.

PMID:
21940052
17.

Lipoxin A4 is a novel estrogen receptor modulator.

Russell R, Gori I, Pellegrini C, Kumar R, Achtari C, Canny GO.

FASEB J. 2011 Dec;25(12):4326-37. doi: 10.1096/fj.11-187658. Epub 2011 Sep 1.

PMID:
21885654
18.

Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α.

Gori I, Pellegrini C, Staedler D, Russell R, Jan C, Canny GO.

Mol Cell Endocrinol. 2011 Oct 15;345(1-2):27-37. doi: 10.1016/j.mce.2011.06.043. Epub 2011 Jul 19.

PMID:
21784129
19.

Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials.

Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, Tümmler B, Vavrova V, De Boeck K.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S79-81. doi: 10.1016/S1569-1993(11)60012-X.

20.

Outcome in cystic fibrosis liver disease.

Rowland M, Gallagher CG, O'Laoide R, Canny G, Broderick A, Hayes R, Greally P, Slattery D, Daly L, Durie P, Bourke B.

Am J Gastroenterol. 2011 Jan;106(1):104-9. doi: 10.1038/ajg.2010.316. Epub 2010 Aug 24.

PMID:
20736939
21.

Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.

O'Riordan SM, Hindmarsh P, Hill NR, Matthews DR, George S, Greally P, Canny G, Slattery D, Murphy N, Roche E, Costigan C, Hoey H.

Diabetes Care. 2009 Jun;32(6):1020-2. doi: 10.2337/dc08-1925. Epub 2009 Mar 11.

22.

Bactericidal/permeability-increasing protein (BPI) and BPI homologs at mucosal sites.

Canny G, Levy O.

Trends Immunol. 2008 Nov;29(11):541-7. doi: 10.1016/j.it.2008.07.012. Review.

PMID:
18838299
23.

Bacteria in the intestine, helpful residents or enemies from within?

Canny GO, McCormick BA.

Infect Immun. 2008 Aug;76(8):3360-73. doi: 10.1128/IAI.00187-08. Epub 2008 May 12. Review. No abstract available.

24.

Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs.

Farrell P, Joffe S, Foley L, Canny GJ, Mayne P, Rosenberg M.

Ir Med J. 2007 Sep;100(8):557-60.

PMID:
17955689
25.

Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.

Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan SP.

FASEB J. 2007 Oct;21(12):3162-70. Epub 2007 May 11.

PMID:
17496159
26.

Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells.

Canny GO, Trifonova RT, Kindelberger DW, Colgan SP, Fichorova RN.

J Infect Dis. 2006 Aug 15;194(4):498-502. Epub 2006 Jul 7.

PMID:
16845634
27.

Selective induction of mucin-3 by hypoxia in intestinal epithelia.

Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP.

J Cell Biochem. 2006 Dec 15;99(6):1616-27.

PMID:
16823775
28.
29.

'Peeling paint' dermatitis as a presenting sign of cystic fibrosis.

O'Regan GM, Canny G, Irvine AD.

J Cyst Fibros. 2006 Dec;5(4):257-9. Epub 2006 Jun 21.

30.

Congenital broncho-esophageal fistula: A case report.

Linnane BM, Canny G.

Respir Med. 2006 Oct;100(10):1855-7. Epub 2006 Mar 13.

31.

Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein.

Canny G, Cario E, Lennartsson A, Gullberg U, Brennan C, Levy O, Colgan SP.

Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G557-67. Epub 2005 Nov 10.

32.

Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.

Canny G, Drudy D, Macmathuna P, O'farrelly C, Baird AW.

Life Sci. 2006 Jan 25;78(9):920-5. Epub 2005 Sep 26.

PMID:
16185718
34.

Cystic fibrosis-associated liver disease: a population-based study.

Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, Greally P, Hayes R, Bourke B.

J Pediatr. 2004 Sep;145(3):327-32.

PMID:
15343185
35.

Respiratory function and cosmesis at maturity in infantile-onset scoliosis.

Goldberg CJ, Gillic I, Connaughton O, Moore DP, Fogarty EE, Canny GJ, Dowling FE.

Spine (Phila Pa 1976). 2003 Oct 15;28(20):2397-406.

PMID:
14560091
36.

Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.

Levy O, Canny G, Serhan CN, Colgan SP.

Biochem Soc Trans. 2003 Aug;31(Pt 4):795-800. Review.

PMID:
12887308
37.

Management of a large bronchial haemangioma in an infant.

Watters K, O'Marcaigh A, Canny G, Russell J.

Int J Pediatr Otorhinolaryngol. 2003 Apr;67(4):429-33.

PMID:
12663120
38.

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3902-7. Epub 2002 Mar 12.

39.

A case of pneumomediastinum in paediatric ARDS: to oscillate or not?

McGinley J, Corcoran T, Canny G, O'Hare B.

Paediatr Anaesth. 2001 May;11(3):366-9.

PMID:
11359599
40.

A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.

Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, Alothman G, Tennis O, Canny G.

N Engl J Med. 2000 Sep 7;343(10):689-94.

41.

Altered intracellular pH regulation in neutrophils from patients with cystic fibrosis.

Coakley RJ, Taggart C, Canny G, Greally P, O'Neill SJ, McElvaney NG.

Am J Physiol Lung Cell Mol Physiol. 2000 Jul;279(1):L66-74.

42.

A randomized controlled trial of a 3-year home exercise program in cystic fibrosis.

Schneiderman-Walker J, Pollock SL, Corey M, Wilkes DD, Canny GJ, Pedder L, Reisman JJ.

J Pediatr. 2000 Mar;136(3):304-10.

PMID:
10700685
43.

Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8.

Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG.

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L33-41.

44.

Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma.

Schuh S, Johnson DW, Stephens D, Callahan S, Winders P, Canny GJ.

J Pediatr. 1999 Jul;135(1):22-7.

PMID:
10393599
45.

Hyperplasia of pulmonary neuroendocrine cells in a case of childhood pulmonary emphysema.

Alshehri M, Cutz E, Banzhoff A, Canny G.

Chest. 1997 Aug;112(2):553-6.

PMID:
9266901
46.

Hospitalization patterns in severe acute asthma in children.

Schuh S, Johnson D, Stephens D, Callahan S, Canny G.

Pediatr Pulmonol. 1997 Mar;23(3):184-92.

PMID:
9094726
47.

Does ketotifen have a steroid-sparing effect in childhood asthma?

Canny GJ, Reisman J, Levison H.

Eur Respir J. 1997 Jan;10(1):65-70.

48.

The role of corticosteroids in respiratory diseases of children.

de Benedictis FM, Canny GJ, Levison H.

Pediatr Pulmonol. 1996 Jul;22(1):44-57. Review.

PMID:
8856803
49.

Benign intracranial hypertension in infants with cystic fibrosis.

Bikangaga P, Canny GJ.

Arch Pediatr Adolesc Med. 1996 May;150(5):551-2. No abstract available.

PMID:
8620242
50.

Noninvasive determination of cardiac output in patients with severe airflow limitation.

Lands LC, Canny G, Xu F, Coates AL.

Am J Respir Crit Care Med. 1996 Mar;153(3):981-4.

PMID:
8630583

Supplemental Content

Support Center